Patients with primary Merkel cell carcinoma are at an increased risk of developing a secondary skin cancer vs other malignancies.

Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...

Loomans-Kropp told Business Insider that if initial results from cancer cell tests are promising, she hopes to begin testing metformin as a colon cancer treatment on animals within the next year.

which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new ... May 7, 2025 — A phase I study of a next ...

and demonstrate that speckle phenotypes correlate with outcomes in renal cell carcinoma.

In a deal that could top $1 billion, Merck & Co has teamed up with US biotech Janux Therapeutics to bring T-cell immunotherapies to cancer patients. The agreement sees San Diego-based Janux in ...

The authors present an important set of data implicating ETFDH as an epigenetically suppressed gene in cancer with tumor suppressive functions. The evidence is solid, with the authors demonstrating ...

CAR-T cell therapy is an individualised treatment for patients, currently licensed for people living with some types of blood cancer. More specifically, CAR-T cell therapy engineers a patient’s ...

Visit americanexpress.com to learn more. According to the Pew Research Center, nearly all Americans (97%) have a cell phone of some kind. But that doesn't mean it's gotten more affordable to own one.

The best cell phone plans primarily include sufficient data for your needs. Additionally, a plan can offer relevant perks and features, including bundled discounts on streaming services ...

There is a commercial access agreement for osimertinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...